Sukumar Nagendran - Feb 2, 2022 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Stock symbol
TSHA
Transactions as of
Feb 2, 2022
Transactions value $
$80,100
Form type
4
Date filed
2/3/2022, 08:21 AM
Previous filing
Jun 21, 2021
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $80.1K +10K +52.01% $8.01* 29.2K Feb 2, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.